people who want to learn about and take action on the world�s biggest challenges. extreme poverty ends with you..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..